Lumicell, Inc.   Report issue

For profit
Founded: Wellesley MA United States (2008)
Status: No NME R&D (2008)

Organization Overview

First Clinical Trial
2015
NCT02438358
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Lumicell, Inc.

Active Ingredients

Drugs in Other Trials (1)

lum015 (2 trials)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 1